drugset / Trial / NCT00691678

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

NCT00691678 ↗

Phase 2 Completed 53 enrolled Dawn L. Hershman
NaSingle-groupOpen-labelSupportive care

Summary

Investigators are hoping to learn if glucosamine with chondroitin can help relieve joint pain/stiffness associated with aromatase inhibitors.

Timeline

Start
2008-10
Primary completion
2012-07
Completion
2012-09

Outcome

Met primary endpoint

registry analysis (superiority test); Chondroitin and Glucosamine; p = 0.004; Mean Difference (Final Values) -13.3; t-test, 2 sided NCT00691678 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin Unknown 400 mg —
Subject Glucosamine Small molecule 500 mg —